Atwood & Palmer’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Buy |
55,192
+208
| +0.4% | +$92.6K | 1.54% | 27 |
|
|
2025
Q1 | $26.7M | Sell |
54,984
-406
| -0.7% | -$197K | 1.85% | 21 |
|
|
2024
Q4 | $22.3M | Buy |
55,390
+1,130
| +2% | +$455K | 1.53% | 31 |
|
|
2024
Q3 | $25.2M | Sell |
54,260
-15
| -0% | -$6.98K | 1.72% | 25 |
|
|
2024
Q2 | $25.4M | Buy |
54,275
+142
| +0.3% | +$66.6K | 1.93% | 21 |
|
|
2024
Q1 | $22.6M | Buy |
54,133
+1,633
| +3% | +$683K | 1.72% | 24 |
|
|
2023
Q4 | $21.4M | Buy |
52,500
+180
| +0.3% | +$73.2K | 1.73% | 25 |
|
|
2023
Q3 | $18.2M | Buy |
52,320
+145
| +0.3% | +$50.4K | 1.59% | 27 |
|
|
2023
Q2 | $18.4M | Buy |
+52,175
| New | +$18.4M | 1.64% | 23 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | -$15K | – | 302 |
|
|
2017
Q3 | $15K | Buy |
+100
| New | +$15K | ﹤0.01% | 242 |
|